Cooley has one of the nation's premier pharmaceutical practices with a broad and deep expertise in IP strategies, patent preparation and prosecution, IP landscape and portfolio analysis. We advise emerging and start-up biotech firms as well as global pharmaceutical companies with patent planning and positioning, portfolio development and management, patent life-cycle management, IP due diligence, as well as providing licensing, patentability, validity, infringement and freedom-to-operate reviews and advice.
Cooley's Pharmaceutical Practice team has more than 12 attorneys. We bring to our clients a unique combination of innovative legal advice, deep industry knowledge and practical understanding of our clients' business needs in today's changing and challenging environment. Many of our attorneys hold PhD's in disciplines relevant to the pharmaceutical and biotech industries. We have deep expertise across all aspects of pharmaceutical sciences, including small molecule therapeutics and uses, drug discovery tools, screening assays and methods, genomics, proteomics, vaccines, and cell biology. Many of our attorneys have had substantial industrial experience as in-house counsel at biotech and pharmaceutical companies. Our combined legal and technical experience, skills, and business-centered approach to patent strategies and execution have enabled our clients to effectively use intellectual property as a tool to advance their business objectives.
| Back to Patent Home Page |